Semaglutide is a potent, long-acting GLP-1 receptor agonist studied extensively in preclinical and clinical research for its effects on glycemic regulation, appetite suppression, and body weight management. Its modified structure incorporating fatty acid side chains extends its half-life to approximately one week, enabling sustained receptor engagement in research models. Studies have examined Semaglutide for its influence on insulin secretion, glucagon suppression, gastric emptying, and hypothalamic satiety signaling. It is widely used in metabolic disease research and obesity biology. PeptideBull supplies Semaglutide at research-grade purity for authorized research applications. Not for human consumption or therapeutic use.
Research Articles
GLP-1 Peptides: Semaglutide, Tirzepatide, Retatrutide Comparison
A comprehensive scientific comparison of GLP-1 peptides, including Semaglutide, Tirzepatide, and Retatrutide. Delve into...
Semaglutide: A Comprehensive GLP-1 Receptor Research Guide
A deep dive into the scientific research behind Semaglutide, exploring its mechanism as a GLP-1 receptor agonist and its...
GLP-1 Peptides: Semaglutide, Tirzepatide, Retatrutide Comparison
Discover the differences and similarities between Semaglutide, Tirzepatide, and Retatrutide. This article delves into th...